Back to Search
RAJ SINGH, M.D.
M.D.
Nephrology Physician
NPI: 1164546719IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A 104464(CA)
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
12939(NV)
Education
OTHER
Class of 2003
Research & Publications (20)
Sensitivity and specificity of postoperative upper GI series following gastric bypass.
PMID 12630617·Obes Surg·2003
8-other
Seasonal air quality profile of inorganic ionic composition of PM(10) near Taj Mahal in Agra, India.
PMID 19669912·Environ Monit Assess·2010
8-other
Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
PMID 19147767·Clin Cancer Res·2009
7-preclinical
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
PMID 18172282·Clin Cancer Res·2008
7-preclinical
Metals concentration associated with respirable particulate matter (PM10) in industrial area of Eastern U.P. India.
PMID 18831333·J Environ Biol·2008
8-other
Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
PMID 19047104·Clin Cancer Res·2008
7-preclinical
Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
PMID 18339887·Cancer Res·2008
7-preclinical
Anti-free radical activities of kaempferol isolated from Acacia nilotica (L.) Willd. Ex. Del.
PMID 18805478·Toxicol In Vitro·2008
8-other
Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents.
PMID 17691907·Curr Cancer Drug Targets·2007
6-review
Sensitivity analysis and evaluation of MicroFacPM: a microscale motor vehicle emission factor model for particulate matter emissions.
PMID 17458461·J Air Waste Manag Assoc·2007
4-observational
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
PMID 17916909·Carcinogenesis·2007
7-preclinical
Evaluation of antioxidant potential of ethyl acetate extract/fractions of Acacia auriculiformis A. Cunn.
PMID 17336438·Food Chem Toxicol·2007
8-other
Natural flavonoids targeting deregulated cell cycle progression in cancer cells.
PMID 16515531·Curr Drug Targets·2006
6-review
Effect of silibinin on the growth and progression of primary lung tumors in mice.
PMID 16788158·J Natl Cancer Inst·2006
7-preclinical
Prostate cancer chemoprevention by silibinin: bench to bedside.
PMID 16637061·Mol Carcinog·2006
6-review
Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells.
PMID 16731746·Mol Cancer Ther·2006
7-preclinical
Mechanisms of action of novel agents for prostate cancer chemoprevention.
PMID 16954429·Endocr Relat Cancer·2006
6-review
Mechanisms and preclinical efficacy of silibinin in preventing skin cancer.
PMID 16084079·Eur J Cancer·2005
6-review
Exploring the mechanisms of molecular recognition by flavins.
PMID 17191991·Chem Biodivers·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1294 S JONES BLVD
LAS VEGAS, NV 89146 - Phone
- (702) 877-1887
Quick Facts
- NPI
- 1164546719
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile